Viveve Medical, Inc.

VIVEOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$2145

P/E Ratio—

52W High$0.001

52W Low$0.0001

Avg Volume3K

Open$0.00

Beta-0.72

Overview

Viveve Medical, Inc. (VIVE) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

VIVE · earnings · updated Jun 8, 2026

Latest Earnings

Q4 FY2022Report Date: Nov 10, 2022

EPS Actual

-$0.59

Est. -$0.66 · +10.6%

Revenue

$0.00B

Fiscal Period

Q4 FY2022

FY ends December

Report Date

Nov 10, 2022

After Market Close

▲ Beat EPS✓ 1-Quarter EPS Beat Streak

VIVE reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$0.09

Rev. $41.31B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$0.09

Rev. Est.$41.31B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 14, 2026	—	—	—	—	—	—
◌ Q2 FY2026	May 29, 2026	—	—	—	—	—	—
◌ Q1 FY2026	Mar 20, 2026	$0.01	—	—	—	$0.01B	—
◌ Q4 FY2024	Oct 3, 2024	—	—	—	—	—	—
◌ Q3 FY2024	Sep 23, 2024	—	—	—	—	$0.00B	—
◌ Q2 FY2024	Jun 27, 2024	—	—	—	—	$0.00B	—
◌ Q1 FY2024	Feb 12, 2024	—	—	—	—	$0.00B	—
◌ Q4 FY2023	Nov 27, 2023	—	—	—	—	$0.00B	—

Q3 FY2026

Aug 14, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2026

May 29, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 20, 2026

EPS Actual

—

EPS Est.

$0.01

EPS Surpr.

—

Revenue

—

Q4 FY2024

Oct 3, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Sep 23, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

Jun 27, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2024

Feb 12, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2023

Nov 27, 2023

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2025	$0.01	$0.01	$0.01	1
Q3 FY2025	$0.00	$0.00	$0.00	0
Q2 FY2025	$-0.05	$-0.05	$-0.05	1
Q1 FY2025	$-0.08	$-0.08	$-0.08	1
Q4 FY2024	$-0.23	$-0.23	$-0.23	1
Q3 FY2024	$-0.22	$-0.22	$-0.22	1

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2025	$0.0B	$0.0B	$0.0B	1
Q3 FY2025	$0.0B	$0.0B	$0.0B	1
Q2 FY2025	$0.0B	$0.0B	$0.0B	1
Q1 FY2025	$0.0B	$0.0B	$0.0B	1
Q4 FY2024	$0.0B	$0.0B	$0.0B	1
Q3 FY2024	$0.0B	$0.0B	$0.0B	1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q4 FY2022	Nov 10, 2022	+10.6%	$5,200.00	$5,250.00	+0.96%

Q4 FY2022+0.96%

Report Date

Nov 10, 2022

EPS Beat/Miss

+10.6%

Price Before

$5,200.00

Price After

$5,250.00

Avg Beat Reaction+0.96%

Beat Rate1 / 1 quarters

Largest Move+0.96% (Q4 FY2022)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Viveve Medical, Inc. (VIVE) most recently reported earnings on November 10, 2022 for Q4 FY2022, posting EPS of $-0.59 — beating the analyst consensus of $-0.66 by +10.6%. The next VIVE earnings date is expected around September 1, 2026.

Each quarter, investors track VIVE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. VIVE revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

VIVE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

VIVE earnings · 5 questions

Viveve Medical, Inc.'s next earnings report is expected around September 1, 2026. VIVE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; VIVE historically reports after market close (AMC).

VIVE earnings datewhen is VIVE earningsVIVE next earnings datewhen does VIVE report earningsVIVE earnings calendar

▸ Source: FMP · Viveve Medical, Inc. SEC filings · US GAAP · Viveve Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026